1. Executive Summary 2. Research Methodology 3. In Vitro Diagnostics 3.1 Overview 3.2 Market Analysis 3.2.1 Market Size by Value (Actual & Forecasted) 4. IVD Market Segmentation 4.1 By Products 4.1.1 Global IVD Market Share by Product Type (Actual & Forecasted) 4.2 By Test Location 4.2.1 Global IVD Market Share by Test Location 4.3 By Discipline 4.3.1 Global IVD Market Share by Discipline 4.4 By Application 5. Global In Vitro Diagnostics (IVD) Market Segmentation 5.1 Product Analysis 5.1.1 Global IVD Reagents Market Size (Actual & Forecasted) 5.1.2 Global IVD Instrumentation Market Size (Actual & Forecasted) 5.1.3 IVD Instrumentation Market by Segment 5.1.4 Global IVD Instrument Services Market Size (Actual & Forecasted) 5.2 Technological Analysis 5.2.1 Global Immunodiagnostics Market Size (Actual & Forecasted) 5.2.2 Global Clinical Chemistry Market Size (Actual & Forecasted) 5.2.3 Global Molecular Diagnostics Market Size (Actual & Forecasted) 6. Global In Vitro Diagnostics (IVD) Market Regional Analysis 6.1 European IVD Market Analysis 6.1.1 European IVD Market Size (Actual & Forecasted) 6.1.2 European IVD Market- Country Analysis 7. Market Dynamics 7.1 Growth Drivers 7.1.1 Increasing prevalence of chronic and infectious diseases 7.1.2 Growing geriatric population 7.1.3 Implementation of the Affordable Care Act (ACA) 7.1.4 Demand for Point of Care facilities 7.2 Challenges 7.2.1 Complex Regulatory Framework 7.2.2 Cumbersome Reimbursement Policy 8. Global IVD Market Trends 8.1 VC Funding & IPOs in IVD Market 8.2 Point-of-care(POC) Molecular Test Products 8.3 Emergence of Targeted Genomic Therapies 9. Competitive Landscape 9.1 IVD Market Share by Competitors (Actual & Forecasted) 9.2 Competitors Capability Analysis 10. Company Profiles 10.1 Abbott Laboratories, Inc. 10.1.1 Business Overview 10.1.2 Financial Overview 10.1.3 Business Strategies 10.2 Roche Holding AG 10.2.1 Business Overview 10.2.2 Financial Overview 10.2.3 Business Strategies 10.3 Siemens AG 10.3.1 Business Overview 10.3.2 Financial Overview 10.3.3 Business Strategies 10.4 Danaher Corporation 10.4.1 Business Overview 10.4.2 Financial Overview 10.4.3 Business Strategies

Figure 1: Highlights of IVD Industry since Evolution Figure 2: Global In Vitro Diagnostics (IVD) Market Size by Value, 2009-15 (US$ Billions) Figure 3: Global In Vitro Diagnostics (IVD) Market Size by Value Forecasted, 2016E-20E (US$ Billions) Figure 4: Global In Vitro Diagnostics (IVD) Market Share by Product Type (2015) Figure 5: Global IVD Market Products Market Share by Type, 2012-20E (%) Figure 6: Global IVD Market Share by Test Location (2015) Figure 7: IVD Classification by Technology Table 1: Global IVD Market by Discipline, 2015 (US$ Millions) Figure 8: Global In Vitro Diagnostics (IVD) Market Share by Discipline (2015) Figure 9: IVD Market by Application Figure 10: Global IVD Reagents Market Size by Value, 2012-20E (US$ Billions) Figure 11: Global IVD Instrumentation Market Size by Value, 2012-20E (US$ Billions) Figure 12: Global Instrumentation Market by Segment - Outsourced vs In House Instrumentation Market Share Analysis, 2012-20E (%) Figure 13: Global IVD Instrument Services Market Size by Value, 2012-20E (US$ Billions) Figure 14: Global Immunodiagnostics Market Size, 2012-20E (US$ Billions) Figure 15: Global Clinical Chemistry Market Size, 2012-20E (US$ Billions) Figure 16: Global Molecular Diagnostics Market Size, 2012-20E (US$ Billions) Figure 17: Global IVD Market Share by Region (2015) Figure 18: European IVD Market Size by Value, 2009-15 (US$ Billions) Figure 19: European IVD Market Size by Value Forecasted, 2016E-20E (US$ Billions) Figure 20: European IVD Market Size by Nations, 2014 (US$ Billions) Figure 21: IVD Per Capita in European Nations, 2014 (US$) Figure 22: Percentage of Population with Chronic Disease in the US, 2005-30F Figure 23: Global Ageing Population (65 years and above), 2009-15 (Millions) Table 2: Venture Financing & IPO Deals in In Vitro Diagnostics Market (2015-16) Figure 24: Global In Vitro Diagnostics (IVD) Market Value Share by Competitors (2015) Figure 25: Global In Vitro Diagnostics (IVD) Market Value Share by Competitors (2020E) Table 3: Global IVD Players Capability Analysis Figure 26: Abbott Laboratories Revenue by Business Segment (FY2015) Figure 27: Abbott Laboratories Net Sales, FY2013-FY2015 (US$ Billions) Figure 28: Roche Holding Revenue by Business Segment (FY2015) Figure 29: Roche Holding Revenue, FY2010-FY15 (US$ Billions) Figure 30: Siemens AG Revenue by Business Division (FY2015) Figure 31: Siemens Healthcare Revenue, FY2013-FY2015 (US$ Billions) Figure 32: Danaher Corporation Revenue by Business Segment (FY2015) Figure 33: Danaher Corporation Revenue by Business Segment (FY2015)

Abbott Laboratories, Roche Holding AG, Siemens AG and Danaher Corporation